
Deborah D. Carr
Examiner (ID: 1854, Phone: (571)272-0637 , Office: P/1672 )
| Most Active Art Unit | 1621 |
| Art Unit(s) | 1622, 1692, 1621, 1672, 1202, 1671, 1204, 1691, 2899 |
| Total Applications | 3078 |
| Issued Applications | 2359 |
| Pending Applications | 315 |
| Abandoned Applications | 438 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20598923
[patent_doc_number] => 20260076926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-03-19
[patent_title] => COMPOUNDS FOR USE IN ORGAN PRESERVATION AND ORGAN TRANSPLANTATION
[patent_app_type] => utility
[patent_app_number] => 19/397818
[patent_app_country] => US
[patent_app_date] => 2025-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9665
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19397818
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/397818 | COMPOUNDS FOR USE IN ORGAN PRESERVATION AND ORGAN TRANSPLANTATION | Nov 20, 2025 | Pending |
Array
(
[id] => 20541116
[patent_doc_number] => 20260048004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-02-19
[patent_title] => Concentrated Injectable Tranexamic Acid Compositions and Methods of Use Thereof
[patent_app_type] => utility
[patent_app_number] => 19/366287
[patent_app_country] => US
[patent_app_date] => 2025-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19366287
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/366287 | Concentrated injectable tranexamic acid compositions and methods of use thereof | Oct 21, 2025 | Issued |
Array
(
[id] => 20419077
[patent_doc_number] => 20250381162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-12-18
[patent_title] => S-BETA-HYDROXYBUTYRATE ESTERS FOR IMPROVING METABOLIC FUNCTION
[patent_app_type] => utility
[patent_app_number] => 19/315079
[patent_app_country] => US
[patent_app_date] => 2025-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19315079
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/315079 | S-b-hydroxybutyrate esters for improving metabolic function | Aug 28, 2025 | Issued |
Array
(
[id] => 20700194
[patent_doc_number] => 12622885
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-12
[patent_title] => Short chain fatty acid compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 19/207954
[patent_app_country] => US
[patent_app_date] => 2025-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24879
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19207954
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/207954 | Short chain fatty acid compounds and uses thereof | May 13, 2025 | Issued |
Array
(
[id] => 19938276
[patent_doc_number] => 12310386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-27
[patent_title] => Reducing the risk of viral infection due to viral contaminated feed
[patent_app_type] => utility
[patent_app_number] => 18/892950
[patent_app_country] => US
[patent_app_date] => 2024-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1964
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18892950
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/892950 | Reducing the risk of viral infection due to viral contaminated feed | Sep 22, 2024 | Issued |
Array
(
[id] => 19649967
[patent_doc_number] => 12171727
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-12-24
[patent_title] => Compositions and methods for treating endocrine diseases and disorders
[patent_app_type] => utility
[patent_app_number] => 18/808138
[patent_app_country] => US
[patent_app_date] => 2024-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11351
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18808138
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/808138 | Compositions and methods for treating endocrine diseases and disorders | Aug 18, 2024 | Issued |
Array
(
[id] => 19785784
[patent_doc_number] => 20250059463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-20
[patent_title] => SYSTEM AND METHOD FOR TRIGLYCERIDE MANUFACTURE
[patent_app_type] => utility
[patent_app_number] => 18/807247
[patent_app_country] => US
[patent_app_date] => 2024-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9755
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18807247
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/807247 | System and method for triglyceride manufacture | Aug 15, 2024 | Issued |
Array
(
[id] => 20083571
[patent_doc_number] => 20250213507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-03
[patent_title] => METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/793452
[patent_app_country] => US
[patent_app_date] => 2024-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18793452
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/793452 | METHODS FOR TREATING NEURODEGENERATIVE DISORDERS | Aug 1, 2024 | Pending |
Array
(
[id] => 20031862
[patent_doc_number] => 20250170084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-29
[patent_title] => ACTION OF L-CITRULLINE TO PREVENT OR TREAT ENDOTHELIAL DYSFUNCTION
[patent_app_type] => utility
[patent_app_number] => 18/778782
[patent_app_country] => US
[patent_app_date] => 2024-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18778782
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/778782 | ACTION OF L-CITRULLINE TO PREVENT OR TREAT ENDOTHELIAL DYSFUNCTION | Jul 18, 2024 | Pending |
Array
(
[id] => 20491480
[patent_doc_number] => 12533335
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-27
[patent_title] => Monoglyceride use in animals
[patent_app_type] => utility
[patent_app_number] => 18/776474
[patent_app_country] => US
[patent_app_date] => 2024-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 5303
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18776474
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/776474 | Monoglyceride use in animals | Jul 17, 2024 | Issued |
Array
(
[id] => 19556704
[patent_doc_number] => 20240368496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => MODULAR, MOBILE, AND AUTOMATED SOLVENT EXTRACTION AND DISTILLATION SYSTEMS, AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/774065
[patent_app_country] => US
[patent_app_date] => 2024-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6596
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18774065
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/774065 | Modular, mobile, and automated solvent extraction and distillation systems, and methods of using the same | Jul 15, 2024 | Issued |
Array
(
[id] => 20093317
[patent_doc_number] => 20250223253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-10
[patent_title] => SITE-SPECIFIC ISOTOPIC LABELING OF 1,4-DIENE SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 18/772745
[patent_app_country] => US
[patent_app_date] => 2024-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11923
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18772745
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/772745 | SITE-SPECIFIC ISOTOPIC LABELING OF 1,4-DIENE SYSTEMS | Jul 14, 2024 | Pending |
Array
(
[id] => 19556705
[patent_doc_number] => 20240368497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => METHODS OF REFINING A GRAIN OIL COMPOSITION, AND RELATED COMPOSITIONS AND METHODS OF USING
[patent_app_type] => utility
[patent_app_number] => 18/771787
[patent_app_country] => US
[patent_app_date] => 2024-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18771787
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/771787 | METHODS OF REFINING A GRAIN OIL COMPOSITION, AND RELATED COMPOSITIONS AND METHODS OF USING | Jul 11, 2024 | Pending |
Array
(
[id] => 20491479
[patent_doc_number] => 12533334
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-27
[patent_title] => Compositions and methods for modulating equine fatty acid profiles
[patent_app_type] => utility
[patent_app_number] => 18/745509
[patent_app_country] => US
[patent_app_date] => 2024-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 8090
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18745509
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/745509 | Compositions and methods for modulating equine fatty acid profiles | Jun 16, 2024 | Issued |
Array
(
[id] => 20445119
[patent_doc_number] => 20260001836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-01-01
[patent_title] => METHODS FOR PREPARING (2S,3R,4R)-4,5-DIHYDROXYISOLEUCINE DERIVATIVE AND INTERMEDIATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/994172
[patent_app_country] => US
[patent_app_date] => 2024-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18994172
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/994172 | METHODS FOR PREPARING (2S,3R,4R)-4,5-DIHYDROXYISOLEUCINE DERIVATIVE AND INTERMEDIATES THEREOF | Jun 3, 2024 | Pending |
Array
(
[id] => 19614807
[patent_doc_number] => 20240400487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => SALTS OF TREPROSTINIL
[patent_app_type] => utility
[patent_app_number] => 18/635756
[patent_app_country] => US
[patent_app_date] => 2024-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18635756
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/635756 | SALTS OF TREPROSTINIL | Apr 14, 2024 | Pending |
Array
(
[id] => 19430813
[patent_doc_number] => 20240299311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/610897
[patent_app_country] => US
[patent_app_date] => 2024-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18610897
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/610897 | IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES | Mar 19, 2024 | Abandoned |
Array
(
[id] => 19202691
[patent_doc_number] => 20240174590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => ACETIC ACID PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 18/437574
[patent_app_country] => US
[patent_app_date] => 2024-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13165
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18437574
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/437574 | ACETIC ACID PRODUCTION | Feb 8, 2024 | Pending |
Array
(
[id] => 19503736
[patent_doc_number] => 12115134
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-15
[patent_title] => Compositions and methods for treating endocrine diseases and disorders
[patent_app_type] => utility
[patent_app_number] => 18/430796
[patent_app_country] => US
[patent_app_date] => 2024-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11437
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18430796
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/430796 | Compositions and methods for treating endocrine diseases and disorders | Feb 1, 2024 | Issued |
Array
(
[id] => 20121552
[patent_doc_number] => 20250236583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-24
[patent_title] => CATALYST AND METHODS FOR OLEFIN ACETOXYLATION
[patent_app_type] => utility
[patent_app_number] => 18/421643
[patent_app_country] => US
[patent_app_date] => 2024-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18421643
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/421643 | CATALYST AND METHODS FOR OLEFIN ACETOXYLATION | Jan 23, 2024 | Pending |